Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Revenue Analysis | Historical Sales Growth & Trends - Stocknear

Drugs Made In America Acq...

NASDAQ: DMAA · Real-Time Price · USD
10.25
-0.01 (-0.10%)
At close: Aug 28, 2025, 3:57 PM
10.26
0.06%
After-hours: Aug 28, 2025, 04:00 PM EDT

Drugs Made In America Acquisition Ordinary Shares Revenue

Drugs Made In America Acquisition Ordinary Shares reported an annual revenue of $0, reflecting a undefined% growth. For the quarter ending June 30, 2025, Drugs Made In America Acquisition Ordinary Shares generated $0 in revenue.
Revenue (ttm)
n/a
Revenue Growth
n/a
Price / Sales Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
343.66M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.